Table 2 Patient demographic and clinical characteristics after propensity score matching.
Characteristics | IMPC (n = 324) n | % | IDC (n = 324) n | % | p value |
|---|---|---|---|---|---|
Age, years | 0.077 | ||||
Mean | 52.4 | 51.7 | |||
SDa | 11.0 | 9.7 | |||
Tumour size, cm | 0.370 | ||||
T ≤ 2 | 130 | 40.1 | 126 | 38.9 | |
2 < T ≤ 5 | 181 | 55.9 | 177 | 54.6 | |
T ≥ 5 | 13 | 4.0 | 21 | 6.5 | |
Node status | 0.715 | ||||
0 | 101 | 31.2 | 101 | 31.2 | |
1–3 | 85 | 26.2 | 97 | 29.9 | |
4–9 | 71 | 21.9 | 66 | 20.4 | |
≥10 | 67 | 20.7 | 60 | 18.5 | |
TNM stage | 0.441 | ||||
I | 58 | 17.9 | 54 | 16.7 | |
II | 125 | 38.3 | 141 | 43.5 | |
III | 141 | 43.8 | 129 | 39.8 | |
LVI b | 0.869 | ||||
yes | 231 | 71.3 | 237 | 73.1 | |
no | 72 | 22.2 | 67 | 20.6 | |
unknown | 21 | 6.4 | 20 | 6.2 | |
Hormone status | |||||
ERc positive | 275 | 84.3 | 283 | 87.3 | 0.363 |
PRd positive | 260 | 84.3 | 258 | 79.6 | 0.845 |
HER2e positive | 107 | 33.0 | 100 | 30.9 | 0.555 |
Surgery | 0.609 | ||||
MRMf | 249 | 76.8 | 263 | 81.2 | |
BCSg | 31 | 9.8 | 25 | 7.7 | |
Mastectomy | 28 | 8.6 | 23 | 7.1 | |
Others | 16 | 4.9 | 13 | 4.0 | |
